Landec Corporation (LNDC) News
Filter LNDC News Items
LNDC News Results
|Loading, please wait...|
LNDC News Highlights
- For LNDC, its 30 day story count is now at 4.
- Over the past 14 days, the trend for LNDC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- NOV, HALL and CDMO are the most mentioned tickers in articles about LNDC.
Latest LNDC News From Around the Web
Below are the latest news stories about LANDEC CORP that investors may wish to consider to help them evaluate LNDC as an investment opportunity.
Lifecore Biomedical CEO James G. Hall By Jarrett Banks IPO Edge: Can you give me a short description of what Lifecore does? Lifecore Biomedical is a fully integrated contract development […]
Common stock expected to begin trading tomorrow under new Nasdaq ticker symbol “LFCR” Lifecore global headquarters relocated to Chaska, MN Launches new investor relations website: ir.lifecore.com CHASKA, Minn., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has completed its transition to Lifecore Biomedical, including the change of its name from La
Lifecore Biomedical to Participate in the Stephens Annual Investment Conference on Thursday, November 17, 2022
CHASKA, Minn., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Lifecore” or the “Company”), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. (“Lifecore”) and Curation Foods, Inc. (“Curation Foods”), – today announced that Jim Hall, CEO of Landec Corporation & President of Lifecore, and John Morberg, CFO will be hosting a fireside chat at the Stephens Annual Investment Conference in Nashville, TN. The Company will participate
Landec Expects to Change Corporate Name to Lifecore Biomedical and Ticker Symbol to “LFCR” on November 14
CHASKA, Minn., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Lifecore” or the “Company”) today announced that it expects to effect its previously announced corporate name change to Lifecore Biomedical, Inc. and to cause its common stock to begin trading on Nasdaq under the ticker symbol “LFCR” prior to market open on November 14, 2022. This new ticker symbol will replace the Company’s current ticker symbol “LNDC,” which has been used since its initial public offering in 1
Landec (NASDAQ: LNDC ) reported its Q1 earnings results on Thursday, October 6, 2022 at 07:15 AM. Here''s what investors need to know about the announcement. Earnings Landec missed estimated earnings by 146.15%, reporting an EPS of $-0.32 versus an … Full story available on Benzinga.com
Companies Reporting Before The Bell • Conagra Brands (NYSE: CAG ) is likely to report quarterly earnings at $0.52 per share on revenue of $2.85 billion. • Constellation Brands (NYSE: STZ ) is likely to report quarterly earnings at $2.81 per share on revenue of $2.51 billion. • Landec (NASDAQ: LNDC ) is expected to report quarterly loss at $0.13 per share on revenue of $42.74 million. • AngioDynamics (NASDAQ: ANGO ) is likely to report … Full story available on Benzinga.com
Lifecore segment revenues increased 8.0% to $23.7 million in fiscal 2023 first quarter versus the prior year period Lifecore segment EBITDA increased 8.1% to $2.5 million in fiscal 2023 first quarter versus the prior year period Reiterates fiscal 2023 full year guidance for Lifecore Corporate rebranding to Lifecore Biomedical continues to progress
Landec Corporation (NASDAQ:NASDAQ:LNDC) Q1 2023 Earnings Conference Call October 6, 2022 8:00 AM ET Company Participants Jeff Sonnek - Investor Relations, ICR Jim Hall - Chief Executive…
Landec press release (LNDC): Q1 Non-GAAP EPS of -$0.32.Revenue of $43.35M (+4.1% Y/Y).Lifecore segment revenues increased 8.0% to $23.7 million in fiscal 2023 first quarter versus…
Landec (LNDC) delivered earnings and revenue surprises of -166.67% and 1.89%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?